Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age

作者: Danuta M Skowronski , Travis S Hottes , Janet E McElhaney , Naveed Z Janjua , Suzana Sabaiduc

DOI: 10.1093/INFDIS/JIQ039

关键词:

摘要: Background. Pandemic H1N1 (pH1N1) surveillance data showed lower attack rates but higher risk of severe outcomes with advanced age. We explored immuno-epidemiologic correlates findings including humoral and cell-mediated immunity (CMI). Methods. In an age-based design, ∼100 banked/residual sera per 10-year age stratum were assessed by hemagglutination inhibition (HI) microneutralization (MN) assays for preexisting antibody to pH1N1 recent seasonal H3N2 strains. a separate birth cohort design defined childhood influenza A/subtype priming (1919–1929: H1N1; 1945–1949: 1958–1960: H2N2; 1969–1970: H3N2; 1978–1989: H3N2/H1N1), whole blood was collected from up 50 volunteers cohort. The ratio Th1(IFN-γ):Th2(IL-10) cytokine responses evaluated in vitro. Results. Antibody viruses highest school-age children. Cross-reactive HI/MN low among participants <70 years (yoa; 6%/4% ≥ 40), seroprevalence increased at 70–79 yoa (27%/6%), even more 80–89 (65%/47%), ≥90 (88%/76%). CMI evident all 5 cohorts compared There little differentiation subtype priming, the Th1:Th2 dropped significantly 2 oldest cohorts. Conclusions. Preexisting may have protected very old infection, while diminished contributed greater severity once infected. young, cross-reactive mostly absent, intact against outcomes.

参考文章(38)
G F Rimmelzwaan, A C M Boon, A D M E Osterhaus, J C de Jong, W E P Beyer, A M Palache, Haemagglutination-inhibiting antibody to influenza virus. Developments in biologicals. ,vol. 115, pp. 63- 73 ,(2003)
L Vaillant, G La Ruche, A Tarantola, P Barboza, for the epidemic intelligence team at InVS, Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Eurosurveillance. ,vol. 14, pp. 19309- ,(2009) , 10.2807/ESE.14.33.19309-EN
C W POTTER, J S OXFORD, Determinants of immunity to influenza infection in man. British Medical Bulletin. ,vol. 35, pp. 69- 75 ,(1979) , 10.1093/OXFORDJOURNALS.BMB.A071545
Karlijn Gijzen, Wai Ming Liu, Ildikó Visontai, Fredrik Oftung, Sylvie van der Werf, Gro Ellen Korsvold, Inge Pronk, Ingeborg S. Aaberge, Anna Tüttő, Istvan Jankovics, Mate Jankovics, Beth Gentleman, Janet E. McElhaney, Ernst C. Soethout, Standardization and validation of assays determining cellular immune responses against influenza. Vaccine. ,vol. 28, pp. 3416- 3422 ,(2010) , 10.1016/J.VACCINE.2010.02.076
Wenwei Tu, Huawei Mao, Jian Zheng, Yinping Liu, Susan S. Chiu, Gang Qin, Ping-Lung Chan, Kwok-Tai Lam, Jing Guan, Lijuan Zhang, Yi Guan, Kwok-Yung Yuen, J. S. Malik Peiris, Yu-Lung Lau, Cytotoxic T Lymphocytes Established by Seasonal Human Influenza Cross-React against 2009 Pandemic H1N1 Influenza Virus Journal of Virology. ,vol. 84, pp. 6527- 6535 ,(2010) , 10.1128/JVI.00519-10
Manabu Igarashi, Kimihito Ito, Reiko Yoshida, Daisuke Tomabechi, Hiroshi Kida, Ayato Takada, Predicting the Antigenic Structure of the Pandemic (H1N1) 2009 Influenza Virus Hemagglutinin PLoS ONE. ,vol. 5, pp. e8553- ,(2010) , 10.1371/JOURNAL.PONE.0008553
M B Graham, V L Braciale, T J Braciale, Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. Journal of Experimental Medicine. ,vol. 180, pp. 1273- 1282 ,(1994) , 10.1084/JEM.180.4.1273
Elizabeth Miller, Katja Hoschler, Pia Hardelid, Elaine Stanford, Nick Andrews, Maria Zambon, Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study The Lancet. ,vol. 375, pp. 1100- 1108 ,(2010) , 10.1016/S0140-6736(09)62126-7